SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Response Biomedical (V.RBM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dick Martin who wrote (396)7/23/2001 9:30:21 PM
From: Dick Martin  Read Replies (1) of 655
 
STOCK PICK OF THE WEEK

Vancouver, British Columbia, July 23, 2001. Response Biomedical
Corp. (RBM: CDNX), a developer of leading diagnostic systems, has been
selected by WallStreetCorner.com, as its stock pick of the week.
WallStreetCorner.com, is a U.S. Internet investment information
portal that features small-cap public companies that have the potential to
double in price or more in the next six to twelve months. Mr. Larry Oakley,
editor of WallStreetCorner.com, provides independent editorial on emerging
companies and special situations
As part of his stock selection criteria, Mr. Oakley looks for
companies that have a product or service in a growing market. He seeks
situations that are at an early stage; ones that the investing public has
not yet discovered, and companies that have recently moved or are about to
move from their R&D phase into commercialization of their product.
The view the write-up, please visit
wallstreetcorner.com.
About Response Biomedical Corp.
Response Biomedical develops quantitative, diagnostic tests for use
with its proprietary RAMP Reader for clinical, STAT-lab and point-of-care
applications. The RAMP System reduces the cost of healthcare by allowing
accurate, rapid and easy-to-use tests to be performed in hospitals, clinics,
laboratories and physicians' offices worldwide. The Company's platform
technology allows for the potential development of over 250 medical tests
that are currently performed by traditional laboratory methods. Response
Biomedical's shares are listed on the Canadian Venture Exchange under the
trading symbol "RBM". For further information, visit the Company's website
at responsebio.com.

-30-

The Canadian Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information contained
herein. The statements made in this advisory may contain certain
forward-looking statements that involve a number of risks and uncertainties.
Actual events or results may differ from the Company's expectations.

Company Contact:

John Gomez

Corporate Communications Manager
Response Biomedical Corp.
Tel (604) 681-4101
Fax (604) 412-9830
Email: jgomez@responsebio.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext